University of Texas/Texas AM Investment Management Co (UTIMCO)’s Edwards Lifesciences EW Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,149	Closed	-$1.18M	–	338
2025 Q3	$1.18M	Buy	+15,149	New	+$1.18M	0.17%	74
2024 Q4	–	Sell	-230	Closed	-$15.2K	–	183
2024 Q3	$15.2K	Buy	+230	New	+$16.7K	﹤0.01%	156
2020 Q4	–	Sell	-837	Closed	-$67K	–	46
2020 Q3	$67K	Buy	+837	New	+$65.3K	0.07%	18

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

University of Texas/Texas AM Investment Management Co (UTIMCO)'s EW Position: Q4 2025 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 15,149 shares — an estimated $1.18M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in EW in Q3 2020 and held it in 3 quarters. The position peaked at $1.18M in Q3 2025. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
University of Texas/Texas AM Investment Management Co (UTIMCO) sold 15,149 Edwards Lifesciences shares in Q4 2025, an estimated $1.18M.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Edwards Lifesciences in Q3 2020 and held it in 3 quarters.
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Edwards Lifesciences position peaked at $1.18M in Q3 2025.
1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2025, filed 17 Feb 2026.